Conference Program
| Day 1, Thursday, October 11, 2012 | |
| 09.00-09.15 | Welcome and Introduction Co-chairs |
| 09.15-10.00 | Keynote Lecture 1 |
| Distinct strategies for enhancing cognition: behavioural, pharmacological and molecular-genetic Richard Morris, University of Edinburgh, UK |
|
| 10.00-10.30 | Coffee Break |
| 10.30-12.30 | Oral Session 1: Enhancing Brain Substrates: Plasticity and Memory |
| 10.30-11.00 | Synaptic plasticity in the hippocampus: potential targets for cognitive enhancement Graham Collingridge, University of Bristol, UK |
| 11.00-11.30 | Erasing and enhancing post-consolidation long-term memories by manipulating PKMzeta Todd Sacktor, SUNY Downstate Medical Center, USA |
| 11.30-12.00 | Plasticity thresholds differ between synapses and result in novel, enhancement-related timing rules for LTP Gary Lynch, University of California, Irvine, USA |
| 12.00-12.15 | Short Oral 1 |
| 12.15-12.30 | Short Oral 2 |
| 12.30-13.30 | Lunch |
| 13.30-15.30 | Oral Session 2: Enhancing Brain Substrates: Cortical Systems |
| 13.30-14.00 | Control of attention: animal models and cholinergic mechanisms Martin Sarter, University of Michigan, USA |
| 14.00-14.30 | Translational and theoretical considerations in the search for cognitive enhancers Trevor Robbins, University of Cambridge, UK |
| 14.30-15.00 | Mind does matter: mental training rescues new neurons from death Tracey Shors, Rutgers University, USA |
| 15.00-15.15 | Short Oral 3 |
| 15.15-15.30 | Short Oral 4 |
| 15.30-16.00 | Coffee Break |
| 16.00-18.00 | Oral Session 3: Experience and Genetics 1 |
| 16.00-16.30 | Gene-environment interactions, experience-dependent plasticity and enviromimetic targets in mouse models of cognitive disorders Anthony Hannan, Florey Institute, Australia |
| 16.30-17.00 | Augmented cognitive training Tim Tully, Dart Neuroscience, USA |
| 17.00-17.30 | Using stem cells and mouse models to study autism Ricardo Dolmetsch, Stanford University, USA |
| 17.30-17.45 | Short Oral 5 |
| 17.45-18.00 | Short Oral 6 |
| 18.00-20.30 | Poster Session |
| Day 2, Friday, October 12, 2012 | |
| 08.00-10.00 | Oral Session 4: Treatment: Aging |
| 08.00-08.30 | Challenge and promise of developing new therapies for cognitive deficits in Alzheimer’s disease and schizophrenia Jeffrey Nye, Johnson & Johnson, USA |
| 08.30-09.00 | What did I eat for breakfast? Gut satiety factors and cognition control Danielle Piomelli, ITT, Italy & University of California, Irvine, USA |
| 09.00-09.30 | Neuromodulation by neurotrophic factors and adenosine: consequences for plasticity and ageing Anna Sebastiao, IMM, Lisbon, Portugal |
| 09.30-09.45 | Short Oral 7 |
| 09.45-10.00 | Short Oral 8 |
| 10.00-10.30 | Coffee Break |
| 10.30-12.30 | Oral Session 5: Treatment: Spine Dysfunction |
| 10.30-11.00 | Discovering therapeutics for autism spectrum disorders using mouse models Jacqueline Crawley, NIMH, NIH, USA |
| 11.00-11.30 | Pharmacologic approaches to cognitive enhancement and correction in animals and humans Mark Bear, MIT, USA |
| 11.30-12.00 | Restoring memory formation following neurodegeneration-mediated cognitive impairment Li-Huei Tsai, MIT, USA |
| 12.00-12.15 | Short Oral 9 |
| 12.15-12.30 | Short Oral 10 |
| 12.30-13.30 | Lunch |
| 13.30-15.30 | Oral Session 6: Treatment: MDD and Schizophrenia |
| 13.30-14.00 | Cognitive impairment in major depression and new therapeutic targets Daniel Umbricht, Roche, Switzerland |
| 14.00-14.30 | The promise and challenges of rapid-acting antidepressants John Krystal, Yale University, USA |
| 14.30-15.00 | Functional consequences of positive allosteric modulation of mGlu5 receptors Mark Tricklebank, Lilly, UK |
| 15.00-15.15 | Short Oral 11 |
| 15.15-15.30 | Short Oral 12 |
| 15.30-16.00 | Coffee Break |
| 16.00-18.00 | Oral Session 7: Experience and Genetics 2 |
| 16.00-16.30 | Cognitive enhancement of normal individuals: Now you see it, now you don't Martha Farah, University of Pennsylvania, USA |
| 16.30-17.00 | Manipulating Memory through Epigenetics David Sweatt, University of Alabama at Birmingham, USA |
| 17.00-17.30 | Pharmacological Cognitive Enhancement in Neuropsychiatric Disorders and Healthy People Barbara Sahakian, University of Cambridge, UK |
| 17.30-17.45 | Short Oral 13 |
| 17.45-18.00 | Short Oral 14 |
| 18.00-18.45 | Keynote Lecture 2 |
| Steps toward a molecular biology of benign age related memory loss Eric Kandel, Columbia University, USA |
|
Organised by
Supporting Journal
